Salbutamol (AH3365) 是一种有效的、选择性的、短效的 β2-肾上腺素能受体激动剂，IC50 为 8.93 µM。沙丁胺醇用于治疗哮喘和慢性阻塞性肺病。它对 β2 受体的选择性比 β1 受体高 29 倍，因此它对肺部 β 受体的特异性高于心脏中 β1 肾上腺素能受体。
1、根据实验需要选择合适的溶剂配制储备液 (母液)：对于大多数产品，InvivoChem推荐用DMSO配置母液 (比如：5、10、20mM或者10、20、50 mg/mL浓度），个别水溶性高的产品可直接溶于水。产品在DMSO 、水或其他溶剂中的具体溶解度详见上”溶解度 (体外)”部分;
2、如果您找不到您想要的溶解度信息，或者很难将产品溶解在溶液中，请联系我们;
3、建议使用下列计算器进行相关计算（摩尔浓度计算器、稀释计算器、分子量计算器、重组计算器等）;
4、母液配好之后，将其分装到常规用量，并储存在-20°C或-80°C，尽量减少反复冻融循环。
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
CTID: NCT06473779
Phase: Phase 3 Status: Recruiting
Date: 2024-11-20
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
CTID: NCT06563102
Phase: Phase 4 Status: Recruiting
Date: 2024-11-12
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
CTID: NCT01799538
Phase: Phase 1/Phase 2 Status: Recruiting
Date: 2024-11-04
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
CTID: NCT06152653
Phase: Phase 4 Status: Recruiting
Date: 2024-10-22
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
CTID: NCT03562195
Phase: Phase 3 Status: Completed
Date: 2024-09-19
View More
Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
CTID: NCT04276233
Phase: Phase 4 Status: Completed
Date: 2024-09-19
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
CTID: NCT03199976
Phase: Phase 4 Status: Terminated
Date: 2024-09-19
Cardiovascular Consequences of Inhaled Short-acting Beta-agonist Use
CTID: NCT06027606
Phase: Phase 1 Status: Recruiting
Date: 2024-09-19
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
CTID: NCT04901715
PhaseEarly Phase 1 Status: Recruiting
Date: 2024-08-26
CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma
CTID: NCT06482294
Phase: Phase 2 Status: Active, not recruiting
Date: 2024-07-03
Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women
CTID: NCT06426082
Phase: N/A Status: Not yet recruiting
Date: 2024-05-23
Treating Exacerbations of Asthma With Oral Montelukast in Children
CTID: NCT05819541
Phase: Phase 2 Status: Recruiting
Date: 2024-05-14
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
CTID: NCT04012138
Phase: Phase 4 Status: Recruiting
Date: 2024-04-30
Secondhand Smoke Respiratory Health Study
CTID: NCT02797275
Phase: Phase 4 Status: Active, not recruiting
Date: 2024-04-23
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
CTID: NCT05527704
Phase: Phase 3 Status: Recruiting
Date: 2024-04-18
Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients
CTID: NCT05860244
Phase: Phase 2 Status: Not yet recruiting
Date: 2024-04-12
The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome
CTID: NCT05667727
Phase: Phase 4 Status: Recruiting
Date: 2024-04-09
Nebulized Salbutamol in Acute Renal Colic
CTID: NCT06276231
Phase: N/A Status: Not yet recruiting
Date: 2024-03-19
The Regulatory Function of Inhaled Asthma Medication Salbutamol on Thermogenesis
CTID: NCT06319183
PhaseEarly Phase 1 Status: Not yet recruiting
Date: 2024-03-19
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
CTID: NCT03137303
Phase: Phase 3 Status: Completed
Date: 2024-02-26
Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)
CTID: NCT05550402
Phase: N/A Status: Recruiting
Date: 2024-02-20
Video Assisted Study of Salbutamol Response in Viral Wheezing
CTID: NCT06093152
Phase: Status: Recruiting
Date: 2024-01-22
CF Bronchodilation
CTID: NCT03522831
Phase: N/A Status: Active, not recruiting
Date: 2023-12-14
Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing Tonsillectomy
CTID: NCT06158893
Phase: Phase 4 Status: Not yet recruiting
Date: 2023-12-06
Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis
CTID: NCT01880723
Phase: N/A Status: Completed
Date: 2023-11-29
INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions
CTID: NCT05653024
Phase: Phase 3 Status: Recruiting
Date: 2023-11-29
Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
CTID: NCT04184609
Phase: Phase 4 Status: Withdrawn
Date: 2023-11-07
5 Versus 10 Units of Insulin in Hyperkalemia Management
CTID: NCT06036823
Phase: Phase 4 Status: Recruiting
Date: 2023-10-03
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists
CTID: NCT05457868
Phase: Status: Active, not recruiting
Date: 2023-07-18
Evaluating Bronchodilator Response in Patients With Bronchiectasis
CTID: NCT05932316
Phase: N/A Status: Recruiting
Date: 2023-07-06
Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)
CTID: NCT05087693
Phase: Phase 4 Status: Recruiting
Date: 2023-05-10
Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus
CTID: NCT04929626
Phase: Phase 1 Status: Completed
Date: 2023-04-05
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
CTID: NCT04677959
Phase: Phase 4 Status: Completed
Date: 2023-03-14
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
CTID: NCT01721291
Phase: Phase 4 Status: Completed
Date: 2023-03-06
The Effect of NAC on Lung Function and CT Mucus Score
CTID: NCT03822637
Phase: Phase 4 Status: Recruiting
Date: 2023-02-10
Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden
CTID: NCT01470755
Phase: Phase 2 Status: Completed
Date: 2023-02-06
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
CTID: NCT03890666
Phase: Phase 4 Status: Completed
Date: 2022-12-07
Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma
CTID: NCT03592212
Phase: Status: Unknown status
Date: 2022-11-01
Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation
CTID: NCT05589441
Phase: N/A Status: Unknown status
Date: 2022-10-21
Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
CTID: NCT03814954
Phase: N/A Status: Completed
Date: 2022-08-30
The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls
CTID: NCT04565847
Phase: Phase 2 Status: Completed
Date: 2022-06-16
Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics
CTID: NCT00308685
Phase: Phase 3 Status: Completed
Date: 2022-04-01
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
CTID: NCT05173584
Phase: Phase 4 Status: Unknown status
Date: 2021-12-30
Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
CTID: NCT04558190
Phase: N/A Status: Completed
Date: 2021-12-02
Albuterol HFA MDI in Pediatric Participants With Asthma
CTID: NCT00577655
Phase: Phase 3 Status: Completed
Date: 2021-11-12
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
CTID: NCT03468790
Phase: Phase 3 Status: Completed
Date: 2021-10-11
Effect of Inhaled Albuterol in Pulmonary Hypertension
CTID: NCT03270332
Phase: Phase 2 Status: Completed
Date: 2021-08-30
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)
CTID: NCT05006235
Phase: Phase 1 Status: Completed
Date: 2021-08-16
Albuterol and Immune Cell Composition
CTID: NCT03889379
PhaseEarly Phase 1 Status: Withdrawn
Date: 2021-08-13
Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial
CTID: NCT04584034
Phase: Phase 4 Status: Withdrawn
Date: 2021-07-23
A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
CTID: NCT04488705
Phase: Phase 1 Status: Completed
Date: 2021-05-21
Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma
CTID: NCT02566902
Phase: N/A Status: Completed
Date: 2021-05-06
A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects
CTID: NCT03380429
Phase: Phase 4 Status: Completed
Date: 2021-04-12
Comparison of Nebulizers in ED in Pediatric Asthma Patients
CTID: NCT01951378
Phase: Phase 4 Status: Terminated
Date: 2021-04-08
Effect of Fluticasone Furoate/Vilanterol on EIA in Adolescents
CTID: NCT04750603
Phase: Phase 4 Status: Completed
Date: 2021-02-11
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
CTID: NCT02743663
Phase: Status: Completed
Date: 2021-02-08
Sensor and Electronic Health Records (EHR) Integration Pilot Study
CTID: NCT03357341
Phase: Status: Completed
Date: 2020-11-24
Physiologic Performance Response to Salbutamol
CTID: NCT04615611
Phase: N/A Status: Unknown status
Date: 2020-11-04
Physiological Response to Salbutamol and Exercise
CTID: NCT03902106
Phase: N/A Status: Unknown status
Date: 2020-11-03
Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults
CTID: NCT02802111
Phase: N/A Status: Completed
Date: 2020-10-28
Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
CTID: NCT00497523
Phase: Phase 3 Status: Completed
Date: 2020-08-03
As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
CTID: NCT00382889
Phase: Phase 3 Status: Completed
Date: 2020-08-03
Status Asthmaticus on the PICU; Intravenous Salbutamol
CTID: NCT03493503
Phase: Phase 4 Status: Completed
Date: 2020-07-30
Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
CTID: NCT02573870
Phase: Phase 2 Status: Completed
Date: 2020-07-21
A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma
CTID: NCT03184987
Phase: Phase 3 Status: Completed
Date: 2020-05-29
Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
CTID: NCT03914638
Phase: Phase 2/Phase 3 Status: Unknown status
Date: 2020-04-06
Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease
CTID: NCT00440245
Phase: Phase 4 Status: Completed
Date: 2020-03-27
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
CTID: NCT03620422
Phase: N/A Status: Completed
Date: 2020-02-17
A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD
CTID: NCT02371629
Phase: Phase 4 Status: Completed
Date: 2019-08-09
Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
CTID: NCT03371459
Phase: Phase 2 Status: Completed
Date: 2019-07-23
Effects of Noninvasive Ventilation Compared to Salbutamol
CTID: NCT03430505
Phase: N/A Status: Completed
Date: 2019-07-22
Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease
CTID: NCT01885936
Phase: Phase 1/Phase 2 Status: Completed
Date: 2019-07-15
Albuterol in Individuals With Late Onset Pompe Disease (LOPD)
CTID: NCT01859624
Phase: Phase 1 Status: Completed
Date: 2019-07-05
Repeat Emergency Department Visits Among Patients With Asthma and COPD
CTID: NCT02499887
Phase: N/A Status: Terminated
Date: 2019-06-04
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
CTID: NCT02872597
Phase: Phase 1 Status: Completed
Date: 2019-04-18
Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
CTID: NCT00831376
Phase: Phase 4 Status: Completed
Date: 2019-04-12
------------------
‘Bronchodilators for wheeze in young children presenting to primary care: a randomised, placebo-controlled, multicentre, parallel group trial’
CTID: null
Phase: Phase 4 Status: Prematurely Ended, Ongoing
Date: 2020-07-08
Congenital myopathy intervention study
CTID: null
Phase: Phase 4 Status: Trial now transitioned
Date: 2020-03-31
Salbutamol for analgesia in renal colic: A prospective, randomised, placebo controlled Phase II trial
CTID: null
Phase: Phase 2, Phase 4 Status: GB - no longer in EU/EEA
Date: 2019-07-08
A 12-week, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT008 and PT007 Administered QID in Adults and Children 4 Years of Age or Older with Asthma (DENALI)
CTID: null
Phase: Phase 3 Status: Completed
Date: 2019-06-26
Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia Gravis
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2019-03-28
In vivo efficacy of Salbutamol Sandoz versus salbutamol Ventolin GSK in children with asthma
CTID: null
Phase: Phase 4 Status: Completed
Date: 2018-08-08
A clinical study to assess the feasibility of measuring inhaled medication concentrations in exhaled breath condensate obtained from healthy volunteers and asthma patients and to assess the relationship with clinical endpoints
CTID: null
Phase: Phase 2 Status: Completed
Date: 2017-12-20
A double blind, placebo controlled, randomised dose escalation trial to investigate the safety and efficacy of topical salbutamol in the improvement of scar appearance when applied to approximated wound margins in healthy volunteers.
CTID: null
Phase: Phase 1, Phase 2 Status: Completed
Date: 2017-10-31
Pharmacological effects of acute and accumulated salbutamol in relation to doping analysis
CTID: null
Phase: Phase 2 Status: Completed
Date: 2016-12-14
The pulmonary effect of bronchodilation on adult VSD patients with persistent or surgically corrected VSD
CTID: null
Phase: Phase 4 Status: Completed
Date: 2016-08-15
β2-mimétiques et système nerveux central : effets du salbutamol sur l’excitabilité corticale et l’activation cérébrale (Betactiv)
CTID: null
Phase: Phase 2 Status: Ongoing
Date: 2016-07-06
Effect of bronchodilators on effort induced dyspnoea in patients suffering
CTID: null
Phase: Phase 3 Status: Completed
Date: 2016-02-11
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
CTID: null
Phase: Phase 4 Status: Completed
Date: 2015-11-18
A phase II, randomised, double blind, placebo controlled, six way crossover study to assess the bronchodilator effect of RPL554 administered on top of salbutamol and ipratropium in patients with COPD
CTID: null
Phase: Phase 2 Status: Completed
Date: 2015-09-18
A B2-agonist as a CFTR activator in CF - Part 2
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2015-07-30
Optimising effectiveness and minimising toxicity of intravenous salbutamol in children with acute asthma
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2015-02-02
A randomised, double-blind, placebo-controlled, parallel-group, multi-centre 24-week study to evaluate the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe eosinophilic asthma on markers of asthma control
CTID: null
Phase: Phase 3 Status: Completed
Date: 2014-11-19
Effect of Dual Bronchodilatation on Broncholysis Testing in COPD Patients
CTID: null
Phase: Phase 4 Status: Completed
Date: 2014-09-23
A Phase III, 24 week, randomized, double blind, double dummy, parallel group study (with an extension to 52 weeks in a subset of subjects) comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI administered once-daily in the morning via a dry powder inhaler with budesonide/formoterol 400mcg/12mcg administered twice-daily via a reservoir inhaler in subjects with chronic obstructive pulmonary disease.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2014-09-16
A B2-agonist as a CFTR activator in CF
CTID: null
Phase: Phase 2 Status: Completed
Date: 2014-04-30
A prospective, multicenter, 12-week, randomized open-label study to evaluate the efficacy and safety of glycopyrronium (50 micrograms o.d.) or indacaterol maleate and glycopyrronium bromide fixed-dose combination (110/50 micrograms o.d.) regarding symptoms and health status in patients with moderate chronic obstructive pulmonary disease (COPD) switching from treatment with any standard COPD regimen
CTID: null
Phase: Phase 4 Status: Completed
Date: 2014-02-26
Reversibility of pulmonary function after inhaling salbutamol in different doses in standard and forward leaning body posture in asthmatic children
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2013-11-07
The protective effect of a single dose salbutamol against exercise induced inspiratory airflow obstruction in asthmatic children.
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2013-09-04
The influence of exercise and hydration to the pharmacological response to inhaled terbutalin and salbutamol in men
CTID: null
Phase: Phase 4 Status: Completed
Date: 2013-07-17
Inhaled salbutamol in elective caesarean section
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2012-11-09
The effect of cold air on the airways of elite skaters and the protective role of the OMRON
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2012-10-29
The effects of high dose beta2-agonists on physical performance in healthy male subjects
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2012-09-10
A Phase IV, open-label, prospective, randomised clinical trial to evaluate the usefulness of measuring nitric oxide in exhaled air in the therapeutic management of adult patients with mild asthma
CTID: null
Phase: Phase 4 Status: Completed
Date: 2012-07-23
A 4-Week Randomized Cross-Over Study to Evaluate Daily Lung Function Following the Administration of Albuterol/Salbutamol and Ipratropium in Subjects with Chronic Obstructive Pulmonary Disease
CTID: null
Phase: Phase 4 Status: Completed
Date: 2012-06-18
A PHASE IIA, RANDOMISED, SINGLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, 6 WAY COMPLETE CROSS-OVER, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF 4 DOSES OF LAS100977 QD COMPARED TO PLACEBO AND AN ACTIVE COMPARATOR IN PATIENTS WITH PERSISTENT ASTHMA
CTID: null
Phase: Phase 2 Status: Completed
Date: 2011-08-01
Essai prospectif randomisé, en double aveugle, comparant la Nalbuphine à l'association Hydroxyzine-Salbutamol dans la dystocie de démarrage.
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2010-11-03
Does nebulised hypertonic (3%) saline reduce the duration of hospital admission in infants with bronchiolitis?
CTID: null
Phase: Phase 4 Status: Completed
Date: 2010-05-13
Diagnostic et traitement de l'asthme chez le sportif : la frontière entre la pathologie et le dopage
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2010-02-05
BISOPROLOLIN VAIKUTUS HEMODYNAMIIKKAAN LIEVÄSTI TAI KOHTALAISESTI HYPERTENSIIVISILLÄ MIEHILLÄ: KAKSOISSOKKO, VAIHTOVUOROINEN LUMEKONTROLLOITU TUTKIMUS
CTID: null
Phase: Phase 4 Status: Completed
Date: 2009-11-12
Blood- and urinary concentrations of salbutamol in asthmatics and elite athletes with asthma; comparison between inhalation vs. oral administration.
CTID: null
Phase: Phase 4 Status: Completed
Date: 2009-05-11
Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia.
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2009-03-19
A proof of concept study to evaluate rebound trough airway hyper-responsiveness after single and chronic dosing with levosalbutamol and racemic salbutamol in persistent asthmatics
CTID: null
Phase: Phase 4 Status: Completed
Date: 2009-02-04
Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expiration flow of NO). A single-centre, placebo controlled, randomized, double blind, cross-over study
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2008-12-04
Ipratropio bromuro-albuterol association vs salbutamolo in asthma and gastroesophageal reflux
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2008-10-07
A proof of concept study to evaluate the peak bronchoprotection conferred by single and chronic dosing with levosalbutamol and racemic salbutamol in persistent asthmatics.
CTID: null
Phase: Phase 4 Status: Completed
Date: 2008-09-01
A single dose, randomized, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the onset of relief from methacholine induced bronchoconstriction with fixed combination beclomethasone dipropionate 100 μg plus formoterol fumarate 6 μg/actuation pMDI with HFA-134a propellant (Foster®) versus standard salbutamol pMDI 100 μg/actuation (Ventolin® 100 μg) therapy in asthmatic patients
CTID: null
Phase: Phase 2 Status: Completed
Date: 2008-08-20
A PHASE II RANDOMIZED, DOUBLE-BLIND STUDY VS. PLACEBO FOR THE EVALUATION OF EFFICACY AND TOLERABILITY OF SALBUTAMOL ADMINISTERED BY ORAL ROUTE IN PATIENTS AFFECTED BY SPINAL MUSCULAR ATHROPHY.
CTID: null
Phase: Phase 2 Status: Completed
Date: 2008-07-29
A phase III, randomized, double-blind, triple-dummy, placebo controlled, multicenter, 5- period, single-dose complete block crossover study to determine the onset of action of indacaterol (150 and 300 μg) in patients with moderate to severe COPD using salbutamol (200 μg) and salmeterol/fluticasone (50/500 μg) as active controls.
CTID: null
Phase: Phase 3 Status: Completed
Date: 2008-04-09
A randomised, double-blind, crossover study to investigate the bronchodilatation post-inhalation of GSK961081 alone and with the addition of cumulative doses of short acting bronchodilators (salbutamol and ipratropium bromide) in patients with COPD
CTID: null
Phase: Phase 2 Status: Completed
Date: 2008-04-03
Influence of tiotropium bromide (Spiriva ®) plus salbutamol versus salbutamol on the mucin secretion and sputum properties in subjects with a COPD exacerbation
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2007-12-07
Chemoreflex sensitivity, exercise and beta agonists
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2007-08-30
A SINGLE CENTRE, GAMMA SCINTIGRAPHY STUDY IN ASTHMATIC PATIENTS TO COMPARE PULMONARY DEPOSITION AND PHARMACOKINETICS OF ALBUTEROL INHALATION SOLUTION (AIS) DELIVERED VIA eFLOW NEBULISER AND SALBUTAMOL NEBULISER SOLUTION VIA LC PLUS NEBULISER
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2007-02-21
Ensayo clínico piloto, aleatorizado, controlado con placebo, paralelo, doble ciego, para evaluar el efecto de salbutamol intravenoso sobre marcadores de inflamación en pacientes con síndrome de distrés respiratorio agudo
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2006-07-07
Effect of Oxis on the Efficacy of Mucociliary Clearance in Patients with COPD
CTID: null
Phase: Phase 4 Status: Completed
Date: 2005-04-14
A randomised, placebo-controlled, double-blind, double-dummy, crossover study to assess the onset of action of two inhalations of Symbicort 160/4.5μg compared with two inhalations of Seretide 25/250μg, two inhalations of Ventoline 100μg, and placebo, delivered by pressurised metered dose inhalers, in patients with chronic obstructive pulmonary disease (COPD).
CTID: null
Phase: Phase 3 Status: Completed
Date: 2004-10-08
How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children?
CTID: null
Phase: Phase 4 Status: Completed
Date:
A 12-week, randomised, double-blind, placebo-controlled, parallel group, multinational, phase IIb dose range finding study to evaluate the efficacy and safety of AZD9668 administered orally at 3 dose levels to patients with Chronic Obstructive Pulmonary Disease (COPD) on treatment with tiotropium
CTID: null
Phase: Phase 2 Status: Completed
Date:
A 48-week, multicentre, multinational, randomized, double-blind, 2-arm parallel group study, comparing the efficacy of FOSTER™ for maintenance and reliever versus fixed-dose FOSTER™ for maintenance + salbutamol as reliever in asthmatics ≥18 years of age
CTID: null
Phase: Phase 3 Status: Completed
Date:
A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older with Asthma (MANDALA).
CTID: null
Phase: Phase 3 Status: Ongoing, Completed, GB - no longer in EU/EEA
Date:
Etude de la dose-réponse au bronchodilatateur puis recherche de dose du bronchodilatateur par la technique de l'interruption du débit chez l'enfant siffleur âgé de 2,5 à 6 ans - Etude DORESI.
CTID: null
Phase: Phase 4 Status: Ongoing
Date:
粤公网安备 44011102003439号
463611831
